Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum

BACKGROUND: Quinine (QN) remains the first line anti-malarial drug for the treatment of complicated malaria in Europe and Africa. The emergence of QN resistance has been documented. QN resistance is not yet a significant problem, but there is an urgent need to discover partners for use in combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Parquet, Véronique, Henry, Maud, Wurtz, Nathalie, Dormoi, Jerome, Briolant, Sébastien, Gil, Marine, Baret, Eric, Amalvict, Rémy, Rogier, Christophe, Pradines, Bruno
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882376/
https://www.ncbi.nlm.nih.gov/pubmed/20497586
http://dx.doi.org/10.1186/1475-2875-9-139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882376/
https://www.ncbi.nlm.nih.gov/pubmed/20497586
http://dx.doi.org/10.1186/1475-2875-9-139

Ejemplares similares